Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06539221
Sphingolipids in Asthma Pathogenesis
Sponsor: Peking University Third Hospital
View on ClinicalTrials.gov
Summary
The study aims to investigate the relationship between the small molecule metabolite sphingolipids and asthma clinical features and explore its involvement in asthma pathogenesis.
Official title: Sphingomyelin in Asthma Pathogenesis
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2024-09-01
Completion Date
2026-09-01
Last Updated
2024-08-06
Healthy Volunteers
Yes
Conditions
Locations (1)
Peking university third hospital
Beijing, Beijing Municipality, China